EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-β1 signaling-Reference-Cited by-同舟云学术

EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho/TGF-β1 signaling

Published:2015-02-09 Issue:3 Volume:125 Page:1228-1242
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Lu Ankang,Zuo Caojian,He Yuhu,Chen Guilin,Piao Lingjuan,Zhang Jian,Xiao Bing,Shen Yujun,Tang Juan,Kong Deping,Alberti Sara,Chen Di,Zuo Shenkai,Zhang Qianqian,Yan Shuai,Fei Xiaochun,Yuan Fei,Zhou Bin,Duan Shengzhong,Yu Yu,Lazarus Michael,Su Yunchao,Breyer Richard M.,Funk Colin D.,Yu Ying

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference70 articles.

1. Predicting Survival in Pulmonary Arterial Hypertension

2. Vascular remodeling in pulmonary hypertension

3. Current pathophysiological concepts and management of pulmonary hypertension

4. Cyclooxygenase-2-Linked Attenuation of Hypoxia-Induced Pulmonary Hypertension and Intravascular Thrombosis

5. Cyclooxygenase-2 Expression in Lung in Patients with Congenital Heart Malformations and Pulmonary Arterial Hypertension

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PGE2 synthesis and signaling in the liver physiology and pathophysiology: An update;Prostaglandins & Other Lipid Mediators;2024-10

2. Disease-associated gut microbiome and metabolome changes in rats with chronic hypoxia-induced pulmonary hypertension;Frontiers in Cell and Developmental Biology;2024-07-12

3. Microscopy Image Dataset for Deep Learning-Based Quantitative Assessment of Pulmonary Vascular Changes;Scientific Data;2024-06-15

4. HMGB2 Release Promotes Pulmonary Hypertension and Predicts Severity and Mortality of Patients With Pulmonary Arterial Hypertension;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-06

5. Therapeutic potential and protective role of GRK6 overexpression in pulmonary arterial hypertension;Vascular Pharmacology;2023-12